aTyr Pharma secures legal opinion for stock offering
Cooley LLP issued a legal opinion regarding the validity of up to approximately $80 million in common stock shares sold by aTyr Pharma under an open market sale agreement. This regulatory approval confirms the authorization of the shares amid a corporate financing process.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed